Sawai Group Holdings Co., Ltd.

TSE:4887 Stock Report

Market Cap: JP¥268.4b

Sawai Group Holdings Past Earnings Performance

Past criteria checks 4/6

Sawai Group Holdings's earnings have been declining at an average annual rate of -11%, while the Pharmaceuticals industry saw earnings growing at 4.3% annually. Revenues have been declining at an average rate of 0.1% per year. Sawai Group Holdings's return on equity is 6%, and it has net margins of 9.3%.

Key information

-11.0%

Earnings growth rate

-10.9%

EPS growth rate

Pharmaceuticals Industry Growth3.4%
Revenue growth rate-0.1%
Return on equity6.0%
Net Margin9.3%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors

Dec 20
Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors

Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Nov 30
Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Sep 04
Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Sawai Group Holdings Co., Ltd. (TSE:4887) Shares Could Be 47% Below Their Intrinsic Value Estimate

Aug 12
Sawai Group Holdings Co., Ltd. (TSE:4887) Shares Could Be 47% Below Their Intrinsic Value Estimate

Sawai Group Holdings (TSE:4887) Has A Pretty Healthy Balance Sheet

Jul 27
Sawai Group Holdings (TSE:4887) Has A Pretty Healthy Balance Sheet

Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

May 28
Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

Apr 22
Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

Is Sawai Group Holdings (TSE:4887) A Risky Investment?

Mar 06
Is Sawai Group Holdings (TSE:4887) A Risky Investment?

Revenue & Expenses Breakdown

How Sawai Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4887 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24177,33816,55222,62212,763
30 Jun 24168,20117,75620,06411,746
31 Mar 24176,86217,21823,24412,189
31 Dec 23185,30917,70923,83612,885
30 Sep 23191,32414,54526,48114,460
30 Jun 23205,10212,51331,55615,688
31 Mar 23200,34412,66730,15616,090
31 Dec 22196,280-33,30731,58414,414
30 Sep 22192,928-31,03131,45814,767
30 Jun 22191,561-30,90431,71915,468
31 Mar 22193,816-28,26932,49916,456
31 Dec 21193,14910,83534,08216,952
30 Sep 21194,34910,96234,93715,367
30 Jun 21193,76313,17734,93314,697
31 Mar 21187,21912,34034,85113,397
31 Dec 20184,96819,34847,706-158
30 Sep 20182,22819,10747,214-203
30 Jun 20179,34518,31347,240-629
31 Mar 20182,53719,27933,88812,974
31 Dec 19186,61019,89127,82115,982
30 Sep 19186,03019,83127,31216,067
30 Jun 19186,17720,55426,89217,130
31 Mar 19184,34119,37632,38016,671
31 Dec 18189,52616,77721,60624,692
30 Sep 18186,10215,74326,10421,488
30 Jun 18179,72014,61928,06217,588
31 Mar 18168,06814,01728,48614,533
31 Dec 17147,59216,26828,18110,207
30 Sep 17137,77016,14023,22910,207
30 Jun 17133,12616,21321,10310,207
31 Mar 17132,42815,91420,45510,207
31 Dec 16132,49016,84021,7008,019
30 Sep 16129,95017,22221,3458,019
30 Jun 16127,05416,42120,8978,019
31 Mar 16123,49217,15519,6048,019
31 Dec 15117,64116,35320,6716,109
30 Sep 15114,21015,55419,6376,109
30 Jun 15109,71615,70618,3026,109
31 Mar 15105,45414,05317,9036,109
31 Dec 14102,08313,06418,5255,170
30 Sep 1497,27912,71317,9355,170
30 Jun 1493,04111,86017,6185,170
31 Mar 1489,82312,19216,5825,170
31 Dec 1387,42313,01716,2264,550

Quality Earnings: 4887 has high quality earnings.

Growing Profit Margin: 4887's current net profit margins (9.3%) are higher than last year (7.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4887's earnings have declined by 11% per year over the past 5 years.

Accelerating Growth: 4887's earnings growth over the past year (13.8%) exceeds its 5-year average (-11% per year).

Earnings vs Industry: 4887 earnings growth over the past year (13.8%) exceeded the Pharmaceuticals industry 12.2%.


Return on Equity

High ROE: 4887's Return on Equity (6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 07:52
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sawai Group Holdings Co., Ltd. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Inc